Loading chat...
IN SB0310
Bill
Status
1/7/2019
Primary Sponsor
James Merritt
Click for details
AI Summary
-
Supervising physicians for office-based opioid treatment must hold a federal SAMHSA waiver and valid DEA registration number specifically authorizing treatment in an office-based setting
-
Providers must perform initial assessments including medical history, substance use history, mental health evaluation, pregnancy testing for women of childbearing age, and clinical opiate withdrawal scale (COWS) documentation
-
Patients must be examined in person at least monthly until stable, then every three months, with toxicology screening and INSPECT database reviews required at least four times per year
-
Informed consent requirements include patient acknowledgment of treatment goals, consent to drug monitoring and random pill counts, agreement to safe medication storage, and understanding that inadequate progress may result in referral to higher-level care
-
Exemptions apply to correctional facilities, licensed hospitals providing inpatient services, residential facilities, SAMHSA-certified opioid treatment programs, and state institutions
Legislative Description
Outpatient based opioid treatment providers. Specifies requirements that a health care provider that prescribes for a patient in an office based opioid treatment setting must meet in the treatment of the patient.
Last Action
Senator Niezgodski added as coauthor
1/28/2019